Seven MEITL patients (78%), seven ATLL (64%), and one other group (EBV+ CD56+ TNKCL, 14%) showed more than two colorectal lesions by lymphoma cells. This evidence concerns the gene NCAM1 and adult T-cell leukemia/lymphoma.